Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

60.23
+1.061.79%
Post-market: 60.03-0.2000-0.33%19:51 EST
Volume:8.15M
Turnover:488.77M
Market Cap:122.75B
PE:16.29
High:60.37
Open:59.29
Low:59.25
Close:59.17
52wk High:60.37
52wk Low:32.38
Shares:2.04B
Float Shares:1.95B
Volume Ratio:1.02
T/O Rate:0.42%
Dividend:1.74
Dividend Rate:2.89%
EPS(TTM):3.70
EPS(LYR):3.74
ROE:43.31%
ROA:9.78%
PB:5.51
PE(LYR):16.12

Loading ...

GSK announces European Commission approved Nucala

TIPRANKS
·
Feb 06

Kepler Capital Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Feb 06

GlaxoSmithKline (GSK) Gets a Buy from Shore Capital

TIPRANKS
·
Feb 06

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Feb 06

GSK Discloses Share Sales by Senior Executive and Associated Insider

TIPRANKS
·
Feb 05

GlaxoSmithKline (GSK) Receives a Hold from UBS

TIPRANKS
·
Feb 05

GSK Climbs Wednesday, Outperforms Market

Dow Jones
·
Feb 05

GSK Up Nearly 7%, On Pace for Highest Close Since April 2014 -- Data Talk

Dow Jones
·
Feb 05

Stock Track | GlaxoSmithKline Soars 6.43% Intraday on Strong Q4 Earnings Beat, Dividend Hike and Upbeat Guidance

Stock Track
·
Feb 04

GSK Stock Smashes 52-Week High On Strong Quarter, Dividend Hike

Benzinga
·
Feb 04

GSK Could Still Face U.S. Drug Pricing Headwind -- Market Talk

Dow Jones
·
Feb 04

GSK: Solid Near‑Term Delivery, Enhanced Shareholder Returns, and Compelling 2031 Growth Upside Support Buy Rating

TIPRANKS
·
Feb 04

Dow Jones Top Company Headlines at 7 AM ET: Wegovy Maker Novo Nordisk's Shares Slump After Guidance Disappoints | GE ...

Dow Jones
·
Feb 04

GSK expects dividend of 70p per share for FY26

TIPRANKS
·
Feb 04

Stock Track | GlaxoSmithKline Soars 5.02% in Pre-market on Strong Q4 Earnings Beat and Upbeat 2026 Outlook

Stock Track
·
Feb 04

Jefferies Remains a Buy on GlaxoSmithKline (GSK)

TIPRANKS
·
Feb 04

GlaxoSmithKline Exceeds Q4 Profit Expectations Driven by HIV Medications

Stock News
·
Feb 04

GSK Q4 Core Earnings, Sales Increase; 2026 Growth Outlook Issued

MT Newswires Live
·
Feb 04

GSK's Guidance Implies FX Headwind -- Market Talk

Dow Jones
·
Feb 04

GSK Q4 Adj. EPS $0.68 Beats $0.64 Estimate, Sales $11.460B Beat $11.190B Estimate

Benzinga
·
Feb 04